DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/wh5qsz/global_renal) has announced the addition of the "Global Renal Cancer Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Renal Cancer Drug Pipeline Capsule - 2012 Update' provides information on key Research and Development activities (R&D) in the global Renal Cancer market. It covers active Renal Cancer pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Topics Covered:
1. Renal Cancer - Disease Overview
2. Renal Cancer Pipeline Overview
3. Renal Cancer Phase 3 Clinical Trial Pipeline Insights
4. Renal Cancer Phase 2 Clinical Trial Pipeline Insights
5. Renal Cancer Phase 1 Clinical Trial Pipeline Insights
6. Renal Cancer Preclinical Research Pipeline Insights
7. Renal Cancer Discovery Stage Pipeline Insights
8. Renal Cancer Drug Development Activities - Geographic Landscape
8.1. Renal Cancer R&D Activities in North America
8.2. Renal Cancer R&D Activities in Europe
9. Renal Cancer Pipeline - Licensing Activities
Table 1. Renal Cancer Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Renal Cancer Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Renal Cancer Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Renal Cancer Pipeline Molecules - Preclinical Research
Table 5. Renal Cancer Pipeline Molecules - Drug Discovery
Table 6. Renal Cancer R&D Activities by Geography
Table 7. Renal Cancer Pipeline Molecules - North America
Table 8. Renal Cancer Pipeline Molecules - Europe
Table 9. Renal Cancer Pipeline - Licensing Activities
Figure 1. Renal Cancer Pipeline Molecules by R&D Stage
Figure 2. Renal Cancer R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/wh5qsz/global_renal